Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer

Journal of Urology

Volumn 171, Issue 3, 2004, Pages 1117-1121

  Han, Ken Ryu ^a   Seligson, David B ^a   Liu, Xueli ^a   Horvath, Steve ^a   Shintaku, Peter I ^a   Thomas, George V ^a   Said, Jonathan W ^a   Reiter, Robert E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mice; Prostate; Prostate stem cell antigen; Prostatic neoplasms; Tumor markers, biological

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE STEM CELL ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; DNA MICROARRAY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

EID: 1542267902     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000109982.60619.93     Document Type: Article

References (19)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. and Thun, M. J.: Cancer statistics, 2003. CA Cancer J Clin, 53: 5, 2003
2. Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E. et al: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA, 95: 1735, 1998
3. Saffran, D. C., Raitano, A. B., Hubert, R. S., Witte, O. N., Reiter, R. E. and Jakobovits, A.: Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA, 98: 2658, 2001
4. Gu, Z., Thomas, G., Yamashiro, J., Shintaku, I. P., Dorey, F., Raitano, A. et al: Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 19: 1288, 2000
5. Ross, S., Spencer, S. D., Holcomb, I., Tan, C., Hongo, J., Devaux, B. et al: Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res, 62: 2546, 2002
6. Fleming, I. D., Cooper, J. S., Hensen, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P. et al: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997
7. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S. et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 4: 844, 1998
8. Liao, S. Y., Brewer, C., Zavada, J., Pastorek, J., Pastorekova, S., Manetta, A. et al: Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol, 145: 598, 1994
9. Harrell, F. E.: Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer Publishing, 2001
10. Hara, N., Kasahara, T., Kawasaki, T., Bilim, V., Obara, K., Takahashi, K. et al: Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Clin Cancer Res, 8: 1794, 2002
11. Partin, A. W., Kattan, M. W., Subong, E. N., Walsh, P. C., Wojno, K. J., Oesterling, J. E. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
12. Jenkins, R. B., Qian, J., Lieber, M. M. and Bostwick, D. G.: Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res, 57: 524, 1997
13. Reiter, R. E., Sato, I., Thomas, G., Qian, J., Gu, Z., Watabe, T. et al: Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer, 27: 95, 2000
14. Dubey, P., Wu, H., Reiter, R. E. and Witte, O. N.: Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression. Cancer Res, 61: 3256, 2001
15. Ross, S., Spencer, S. D., Lasky, L. A. and Koeppen, H.: Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis. Am J Pathol, 158: 809, 2001
16. Yang, D., Holt, G. E., Velders, M. P., Kwon, E. D. and Kast, W. M.: Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res, 61: 5857, 2001
17. Magee, J. A., Abdulkadir, S. A. and Milbrandt, J.: Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell, 3: 273, 2003
18. Watabe, T., Lin, M., Ide, H., Donjacour, A. A., Cunha, G. R., Witte, O. N. et al: Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci USA, 99: 401, 2002
19. Tran, C. P., Lin, C., Yamashiro, J. and Reiter, R. E.: Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res, 1: 113, 2002